Table VII.1: How States Rated the Usefulness of Information on FDAís Website Related to Drug Compounding, by Number of Reporting States
  Level of usefulness (number of states)
Information on the Food and Drug Administrationís (FDA) website Very useful Moderately useful Slightly useful Not at all useful Have not used No response
General information on drug compounding 9 25 9 0 6 1
Information related to section 503A of the Federal Food, Drug, and Cosmetic Act 13 21 9 1 5 1
Information related to section 503B of the Federal Food, Drug, and Cosmetic Act 13 23 8 0 5 1
Information on the federal Drug Quality and Security Act (Pub. L. No. 113-54) 10 23 10 1 5 1
Information on and time frames for FDA's plans for implementing the federal Drug Quality and Security Act (Pub. L. No. 113-54) 9 15 14 6 5 1
FDA proposed and final rules related to drug compounding 6 23 12 3 5 1
FDA guidance documents related to drug compounding 9 17 14 3 6 1

Source: GAO survey of state pharmacy regulatory bodies, survey question 46. | GAO-17-363SP
Note: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.